JPRN-jRCT2031230196招募中1 期
Phase 1 study of Tobemstomig in patients with advanced solid tumors
oriko Yanagitani0 个研究点目标入组 18 人开始时间: 2023年7月1日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •ECOG PS of 0 or 1
- •- Life expectancy for at least 12 weeks
- •- Histologically or cytologically confirmed solid tumor
- •- Failure to respond to, or not suitable for, standard therapy, or progression/recurrence of cancer without established standard therapy
- •- Patients with imaging lesions evaluable by RECIST v1.1
排除标准
- •- Pregnant or lactating patients
- •- Patients with symptomatic or treated central nervous system tumor or metastases to the central nervous system
- •- Patients with spinal cord compression lesions
- •- Patients with significant cardiovascular disease
- •- Patients with significant liver disease
- •- HIV, active HBV, active HCV positive
- •- Dementia or altered mental status that would preclude obtaining informed consent
- •- Pleural effusion, pericardial effusion, or ascites requiring drainage.
- •- Patients with significant autoimmune disease or immunodeficiency
研究者
相似试验
已完成
1 期
Phase I study of Tiragolumab in patients with advanced solid tumorsAdvanced solid tumorJPRN-jRCT2080224926Chugai Pharmaceutical Co., Ltd.6
进行中（未招募）
不适用
Phase I/II study on concomitant and adjuvant Temozolomide and Radiotherapy with or without PTK787/ZK222584 in newly diagnosed GBMGlioblastoma multiformeEUCTR2004-003896-35-DEEuropean Organisation for Research and Treatment of Cancer220
进行中（未招募）
不适用
Phase I/II study on concomitant and adjuvant Temozolomide and Radiotherapy with or without PTK787/ZK222584 in newly diagnosed GBMGlioblastoma multiformeEUCTR2004-003896-35-GBEuropean Organisation for Research and Treatment of Cancer220
进行中（未招募）
1 期
Phase I/II study on concomitant and adjuvant Temozolomide and Radiotherapy with or without PTK787/ZK222584 in newly diagnosed GBMMedDRA version: 7.1Level: PTClassification code 10018337Glioblastoma multiformeEUCTR2004-003896-35-ATEuropean Organisation for Research and Treatment of Cancer220
进行中（未招募）
不适用
Phase I/II study on concomitant and adjuvant Temozolomide and Radiotherapy with or without PTK787/ZK222584 in newly diagnosed GBMGlioblastoma multiformeEUCTR2004-003896-35-BEEuropean Organisation for Research and Treatment of Cancer220